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Abstract MCRs are known to be expressed predomi-
nantly in the brain where they mediate metabolic and anti-
inXammatory functions. Leptin plays an important role in
appetite and energy regulation via signaling through mela-
nocortin receptors (MCRs) in the brain. As serum levels of
MCR ligands are elevated in a clinical situation [acute-
phase response (APR)] to tissue damage, where the liver is
responsible for the metabolic changes, we studied hepatic
gene expression of MCRs in a model of muscle tissue dam-
age induced by turpentine oil (TO) injection in rats. A sig-
niWcant increase in gene expression of all Wve MCRs
(MC4R was the highest) in liver at the RNA and protein
level was detected after TO injection. A similar pattern of
increase was also found in the brain. Immunohistology
showed MC4R in the cytoplasm, but also in the nucleus of
parenchymal and non-parenchymal liver cells, whereas
MC3R-positivity was mainly cytoplasmic. A time-depen-
dent migration of MC4R protein from the cytoplasm into
the nucleus was observed during APR, in parallel with an
increase in -MSH and leptin serum levels. An increase of
MC4R was detected at the protein level in wild-type mice,
while such an increase was not observed in IL-6ko mice
during APR. Moreover, treatment of isolated liver cells
with melanocortin agonists (-MSH and THIQ) inhibited
the endotoxin-induced upregulation of the acute-phase
cytokine (IL-6, IL1 and TNF-) gene expression in
KupVer cells and of chemokine gene expression in hepato-
cytes. MCRs are expressed not only in the brain, but also in
liver cells and their gene expression in liver and brain tissue
is upregulated during APR. Due to the presence of speciWc
ligands in the serum, they may mediate metabolic changes
and exert a protective eVect on liver cells.
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Introduction
The melanocortin system consists of several agonists, two
antagonists and Wve receptors. The agonists, including
-melanocyte-stimulating hormone (-MSH),  -MSH,
-MSH and ACTH, are all derived from tissue-speciWc post-
translational processing of a pre-prohormone, pro-opiomela-
nocortin (POMC) (Butler 2006; Mountjoy et al. 1992). Five
melanocortin receptors (MCRs) mediate the diverse actions
of the melanocortins. They are numbered MC1R to MC5R
according to the sequence of their cloning (Mountjoy et al.
1992). The melanocortin 4 receptor (MC4R), the fourth of
Wve known receptor subtypes, is widely expressed in the
central nervous system (Gantz and Fong 2003; Mountjoy
et al. 1992; Tao 2010). The MC4R, as a part of the central
melanocortin system, is also known for the mediation of
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orexigenic and anorexic signals in the control of appetite,
food intake, body weight control and energy homeostasis
(Gantz and Fong 2003). In fact, chronic central and periphe-
ral administration of non-selective melanocortin receptor
agonists reduces food consumption and causes weight loss.
Experimental observations on MC4R¡/¡ mice indicate an
imbalance in fat consumption and oxidation compared to the
respective wild-type strain, supporting the notion that this
receptor plays a key role in the regulation of energy expendi-
ture and fatty acid oxidation (Butler 2006).
Besides the melanocortin system, some other circulating
hormones are thought to play an important role as modula-
tors of energy Xow within the organism. For example, the
adipocyte-derived hormone leptin is involved in regulation
of metabolic processes by acting on the brain (Vrang et al.
2002). In fact, a number of experiments have documented
that circulating leptin enters the brain to interact with hypo-
thalamic neurones regulating appetite and metabolism
(Seeley et al. 1997; Vrang et al. 2002).
It has been reported that leptin is able to induce gene
expression of pro-opiomelanocortin (POMC) in mouse
brain (Vrang et al. 2002) and the role of arcuate POMC
neurons as downstream mediators of leptin’s eVects upon
energy homeostasis is also well recognized (Seeley et al.
1997). Moreover, pharmacological blockade of MC4R
attenuates the ability of leptin to reduce food intake or body
weight in rats (Seeley et al. 1997).
Leptin and melanocortin receptors are known to be abun-
dantly expressed in brain (Seeley et al. 1997). Furthermore,
leptin is thought to regulate hepatic and peripheral tissue
glucose metabolism through interaction with the MCRs
(Shimizu et al. 2007; Toda et al. 2009). Leptin receptors,
however, are also found in the liver (Cohen et al. 2007) rais-
ing the possibility of a similar role there. Indeed, leptin has
been attributed an important role in the regulation of fatty
acid uptake in hepatocytes (Ge et al. 2010). In contrast to
leptin receptors, MCRs have not been described in the liver.
Acute-phase response (APR) is the systemic reaction to
tissue injury and inXammation. It is clinically characterized
by systemic symptoms such as fever, weakness, adinamia,
somnolence and loss of appetite. In the blood, leucocytosis,
increased erythrocyte sedimentation rate, increased serum
level of corticosteroids and dramatic changes in serum
levels of acute-phase proteins (APP) represent the most
striking features of APR (Ramadori and Christ 1999;
Ramadori et al. 2008). Metabolic derangements in APR
include increased resting energy expenditure and proteolysis,
besides hyperglycemia associated with increased glucose
production and oxidation, depressed glycogenesis, insulin
resistance, and increased glucagon and catecholamine
activities (Mizock 1995).
During acute-phase situations due to tissue damage, the
liver is exposed to the acute-phase mediators produced by
inXammatory cells, which induce metabolic changes and a
dramatic change of the protein synthesis in the hepatocytes.
Furthermore, corpusculate materials like tissue debris and
damaged erythrocytes are taken up by liver macrophages
that stimulate them to synthesize tumor necrosis factor-
(TNF-), interleukin-6 (IL-6) and interleukin-1 (IL-1) or
interferon- (Ramadori and Christ 1999). These cytokines
together with those synthesized at the injury site can also
induce synthesis of other mediators by the KupVer cells and
by the hepatocytes such as CXCL8 (IL-8) (Sheikh et al.
2006) or CCL2 (MCP-1) (Malik et al. 2010b).
Some of these mediators are also known to exert meta-
bolic eVects. In fact, upregulation of CXCL10 is thought to
be linked to increased fatty acid production in the liver of
obese hepatitis C virus (HCV)-infected patients (Palmer
et al. 2010). Furthermore, CCL2 is known to be associated
with insulin resistance (Sartipy and LoskutoV 2003) as was
reported for IL-6 (Wallenius et al. 2002).
Hepatocytes not only express the receptors for diVerent
cytokines, but also receptors for several hormones such as
glucocorticoids (Engblom et al. 2007), thyroid hormones
(Malik et al. 2010a), insulin (Fehlmann et al. 1982) and
leptin as mentioned above (Vrang et al. 2002). Moreover, it
is also known that the leptin serum level is elevated in
acute-phase conditions, caused by the administration of,
e.g., lipopolysaccharide (LPS) or turpentine oil (TO)
(Faggioni et al. 1998).
According to previous reports, expression of MCRs was
mainly found in the murine central nervous system (CNS)
(Gantz and Fong 2003; Mountjoy et al. 1992), from where
they can exert their eVects on other organs (Toda et al.
2009) outside the brain, such as the liver (Bitto et al. 2011).
However, the detection or direct inXuence of MCRs in the
liver has not been reported in the literature so far.
As mentioned above, the liver is the major metabolic
organ and also the main target organ during APR. The pres-
ent study addresses the question of whether the MCRs are
expressed in rat and mouse liver cells. Apart from detecting
MC4R in the liver and in liver cells, we also demonstrate that
tissue damage induced by the intra-muscular administration
of turpentine oil can induce changes in the hepatic expression
of MCRs at the mRNA and protein level. The results of our
in vitro experiments suggest that these changes could have an
important metabolic and eventually local anti-inXammatory
function under normal and pathological conditions.
Methods
Antibodies
A rabbit polyclonal antibody speciWc to MC4R and MC3R
was obtained from Abcam (Cambridge, USA); a monoclonalHistochem Cell Biol (2012) 137:279–291 281
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antibody speciWc to -actin was purchased from Sigma
(Munich, Germany). We also bought mouse anti-rat ED1
monoclonal antibody, Serotec (Duesseldorf, Germany),
mouse anti-SMA Sigma (Munich, Germany) and mouse anti-
CK19 Novocastra (Newcastle upon Tyne, UK) antibodies.
Induction of acute-phase reaction (APR)
APR was induced and organs were removed as described
previously (Ramadori et al. 2010). BrieXy, tissue damage
was induced by injecting 5 ml/kg TO to male Wistar rats
(about 200 g body weight) and 10 ml/kg to male B6.129S2-
Il6tm1Kopf (IL-6 KO) mice and male C57BL/6J (wild-type)
mice (about 25–28 g body weight) in both right and left hind
limbs of the animals; and an intraperitoneal injection with
50 g LPS from E. coli serum type was given. Control ani-
mals were treated in the same way for each time point, but
with saline injection in both limbs. All animals were cared
for according to the university’s guidelines, German regula-
tions for the protection of animals and NIH guidelines.
Isolation of total RNA and real-time-PCR
Total RNA was isolated and converted into cDNA for
RT-PCR from rat tissues and cells according to a protocol
described already (Malik et al. 2010a). The housekeeping
genes ubiquitin C (UBC) and -actin were used as normaliz-
ers. Primer sequences used are shown in Table 1. All samples
were assayed in duplicate. The cDNA was ampliWed by run-
ning RT-PCR samples in a 1% agarose electrophoresis gel at
80 V for 1 h. DNA bands were visualized by intercalating
ethidium bromide staining (Sigma, Munich, Germany).
Tissue sections and immunohistochemistry
Peroxidase staining (POD) and immunoXuorescence stain-
ing were performed as described before (Malik et al.
2010b) with an antibody directed against MC4R diluted in
PBS in the ratio of 1:100.
Isolation of tissue lysates, cytosolic lysates and nuclear 
protein extracts
Tissue lysates, nuclear protein and cytosolic extracts from
rat liver were prepared as described previously (Malik et al.
2010a; Ramadori et al. 2010).
Immunoprecipitation
As much as 40 l of liver tissue homogenate and 400 l of
PBS containing protease inhibitors (Roche, Mannheim,
Germany) were incubated with 50 l protein A-agarose
(Roche, Mannheim, Germany) for 1 h at 4°C under rota-
tion. The sample was centrifuged for 30 s at 6,000 rpm and
4 l of the rabbit polyclonal antibody against MC4R was
added to the supernatant. After incubation for 6 h at 4°C
under rotation, the sample was incubated with 50 l of pro-
tein A-agarose for 16 h under the same conditions. The
sample was centrifuged for 5 min at 6,000 rpm and the
supernatant was discharged. The pellet was washed with
PBS and then resuspended in 25 l of ultrapure water, and
15 l of the suspension was analyzed with Western blot.
Western blot analysis
The Western blot was performed as described previously
(Malik et al. 2010a) by using 50 g total protein and 30 g
nuclear extracts. The primary antibody to MC4R and
MC3R was used at a 1:100 dilution.
Immunizing peptide
For experiments with the immunizing peptide, we used a
concentration of the rabbit polyclonal anti-MC4R antibody
Table 1 Rat primer sequences 
used in this study
Primer 5–3 Forward 5–3 Reverse
MC1R GGTGTCCAGTCTCTGCTTCC GGGACAGTGTCACAATGCTG
MC2R CGCTACATCACCATCTTCCA CCGCTCCCTGTACAGAACAT
MC3R GGCGTGATGTTCATCGTCTA GCGAAGAGGAACATGTGGAT
MC4R CAC AGT ATC GGG CGT TCT TT GTA ATT GCG CCC TTC ATG TT
MC5R TGTTCGACTCCATGATCTGC CGTCATGATGTGGTGGTAGC
IL-6 GTC AAC TCC ATC TGC CCT TCA G GGC AGT GGC TGT CAA CAA CAT
TNF- ACA AGG CTG CCC CGA CTA T CTC CTG GTA TGA AGT GGC AAA TC
IL-1 TAC CTA TGT CTT GCC CGT GGA G ATC ATC CCA CGA GTC ACA GAG G
CXCL10 CTGTCGTTCTCTGCCTCGTG GGATCCCTTGAGTCCCACTCA
CCL2 AGGCAGATGCAGTTAATGCCC ACACCTGCTGCTGGTGATTCTC
-Actin ACCACCATGTACCCAGGCATT CCACACAGAGTACTTGCGCTCA
UBC CACCAAGAAGGTCAAACAGGAA AAGACACCTCCCCATCAAACC282 Histochem Cell Biol (2012) 137:279–291
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of 2 g/l diluted in TBS-T with 2.5% milk divided equally
into two tubes. Into the Wrst tube was added 1 g/ml of
MC4R immunizing peptide (Abcam, Cambridge, USA). The
second tube contained the anti-MC4R antibody with no
immunizing peptide. Both tubes were incubated at room
temperature for 30 min. A membrane containing liver tissue
lysate in all lanes was split in half. One piece of the mem-
brane was incubated with the solution containing the anti-
MC4R antibody that was neutralized with the immunizing
peptide, and the other one with the untreated antibody.
Enzyme-linked immunosorbent assay (ELISA)
-MSH (ELISA for -MSH: cat. no: EK-043-01, Phoenix
Pharmaceuticals, Burlingame, USA) and leptin (cat. no.
RL-83K Millipore, Billerica, USA) levels in serum were
determined using commercially available ELISA kits
according to the instructions of the manufacturer.
Isolation of rat liver macrophages (KupVer cells) 
and hepatocytes
KupVer cells and hepatocytes were isolated according to
the method described previously (Malik et al. 2010b) The
KupVer cells were exposed to 5 M -MSH (Tocris Biosci-
ence, Missouri, USA) and 5 M THIQ ([(N-[(3R)-1,2,3,
4-tetrahydroisoquinolinium-3-ylcarbonyl]-(1R)-1-(4-chloro-
benzyl)-2-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)
piperidin-1-yl]-2-oxoethylamine) (Tocris Bioscience, Missouri,
USA) in the presence or absence of 10 g/ml concentration
of LPS (Sigma, Munich, Germany), whereas hepatocytes
were only exposed to 5 M -MSH and 5 M THIQ in
3-ml cell culture medium. The KupVer cells and hepato-
cytes were then harvested in all in vitro experiments at 1, 3
and 6 h after treatment. Non-treated cells of all studied time
points served as controls in all experiments.
Statistical analysis
The PCR data were analyzed using Graph Pad Prism 4 soft-
ware (San Diego, USA). All experimental errors are shown
as SEM. Statistical signiWcance was calculated by one-way
ANOVA and Dunnett’s post hoc test. SigniWcance was
accepted at P <0 . 0 5 .
Results
Change in MCRs gene expression during APR in rat
By means of RT-PCR analysis, the presence of all MCRs
was detected at the mRNA level in the rat liver tissue of
control animals. An early increase of MC4R gene expres-
sion, starting from 1 h and reaching a maximum (6.3 § 2.3-
fold) at 6 h, could be observed after the onset of APR; how-
ever, the gene expression of MC4R remained above the
control level for 36 h. A signiWcant upregulation in gene
expression of MC2R (3.5 § 0.9-fold) and MC5R
(3.8 § 0.9-fold) was detected with a maximum of 12 h,
whereas a mild increase in gene expression of MC1R
(2.6 § 0.3-fold at 2 h) and MC3R (2.1 § 0.2-fold at 12 h)
was also found (Fig. 1a). The detection of MCRs genes in
liver tissue was conWrmed by analyzing the PCR product
through agarose gel-electrophoresis and comparing it to
brain tissue at the RNA level (Fig. 1b).
Immunodetection of MCRs in rat liver and brain tissue 
sections
By means POD and immunoXuorescence staining, using a
rabbit polyclonal antibody against MC4R, a strong nuclear
and to a lesser extent also a cytoplasmic reactivity was
detected mainly in the hepatocytes of the control livers
(Fig. 2; Fig. S1). In liver, positivity was also noticed in and
around the cells of vessel walls of portal and central areas
and in ED1-, CK-19 and SMA+ cells of the liver (Fig. 3).
An increase in the nuclear expression of MC4R with a
parallel decrease in the cytoplasmic expression was also
observed with onset of APR.
Similar to what was observed in the liver, POD and
immunoXuorescence staining directed against MC4R
revealed a pattern of strong nuclear and weak cytoplasmic
positivity in brain sections. The reactivity of MC4R was
not only observed in cells with small nuclei (microglia), but
also in cells with large nuclei (macroglia) in brain sections
(Fig. 4a, b; Fig. S2). In contrast to nuclear expression of
MC4R, a strong cytoplasmic expression of MC3R in the
hepatocytes was detected in the liver tissue. A similar
pattern was also noticed in brain sections (Fig. 5a, b). In brain
tissue sections, MC3R and MC4R were used as a positive
control in this study, as both are known to be constitutively
expressed in the brain (Mountjoy et al. 1992; Tao 2010).
The negative control of the indirect immunoXuorescence
staining, a tissue section incubated with unspeciWc rabbit
immunoglobulins instead of the speciWc antibody to MC4R,
showed no speciWc signals (Figs. S1, S2).
MC4R protein level in liver tissue during APR
Using antibody against MC4R, immunoprecipitation (IP) of
liver tissue proteins revealed an immunoreactive band at 37
and 55 kDa in the liver tissue lysate. However, in the super-
natant using the same antibody, only a band at 55 kDa was
visible, indicating that this band was more abundant than
the lower molecular weight band (Fig. S3). Similar bands
of MC4R were also detected by Western blot analysis in theHistochem Cell Biol (2012) 137:279–291 283
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total liver tissue lysate, cytosol, nuclear fractionation of the
protein and hepatocytes (Fig. 6a). To further assess the speci-
Wcity of the two immunoreactive bands of MC4R by Western
blot, we blocked anti-MC4R antibody using speciWc immu-
nizing peptide against MC4R, but detected no band on the
same membrane. In a second step, after stripping and by
using the antibody against MC4R on the same membrane
again, recovery of both the bands was observed (Fig. 6b).
Furthermore, MC4R protein expression increased in nuclear
extract of the liver with a maximum at 6 h, whereas at the
same time a decrease in cytoplasmic fraction of the liver
could also be detected by Western blot analysis during APR
(Fig. 6c). Consistent with the results obtained in liver, an
increase of MC4R was also observed in rat brain after TO
administration (used as a positive control) (Fig. 6d).
Similar to MC4R, a weak and time-dependent increase
of MC3R was also detected by Western blot in rat liver tis-
sue lysate after TO administration (Fig. 6e).
Changes in -MSH and leptin serum levels 
in TO-treated rats
After TO administration, a mild increase in the level of
-MSH was detected with a maximum at 6 h (60 § 15 pg/ml)
in comparison to control rats (32 § 6.2 pg/ml). These
changes, however, were not statistically signiWcant. The
leptin serum level was elevated early (1 h) above control
(1.2 § 0.7 ng/ml) with a maximum at 6 h (6.3 § 0.8 ng/ml)
and remained signiWcantly increased until 24 h after TO
injection (Fig. 6f).
Detection and change in MC4R protein level in liver tissue 
of wild-type and IL-6-KO mice during APR
Similar to that observed in rat liver tissue, immunoXuores-
cence staining showed a strong nuclear and, to a lesser
extent also a cytoplasmic, reactivity in hepatocytes and
macrophages (F4/80+ cells) of mice (Fig. 7).
By means of immunoblotting, an increase of MC4R pro-
tein levels in the liver tissue lysate of wild-type mice was also
detected after onset of APR. An MC4R protein expression in
the liver of wild-type mice started increasing at 4 h, with a
maximum at 6 h and remained above control level until 24 h
in both TO- and LPS-treated mice. However, a parallel and
time-related decrease with a minimum at 12 h was observed
in IL-6-KO mice in both APR models (Fig. 6g, h).
Immunohistochemical detection of MC4R in primary 
cultured KupVer cells, hepatocytes and Hep G2 cells
By using the antibody against MC4R, immunoXuorescent
detection revealed MC4R in the nucleus and more weakly
Fig. 1 qRT-PCR analysis of to-
tal RNA from rat liver during 
acute-phase reaction. a Fold 
change in mRNA expression of 
MC1R, MC2R, MC3R, MC4R 
and MC5R; the TO-treated liver 
at diVerent time points (1–48 h) 
related to saline-treated controls 
for each time point. qRT-PCR 
was normalized by using two 
housekeeping genes: -actin and 
ubiquitin C. Results represent 
mean value § SEM of three ani-
mals, *p < 0.05. b PCR analysis 
of total RNA extracted from rat 
brain and liver tissue. The PCR 
product was analyzed by agarose 
(1.5%) gel electrophoresis (UV 
light picture)284 Histochem Cell Biol (2012) 137:279–291
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in the cytoplasm of cultured KupVer cells, hepatocytes and
Hep G2 cells, conWrming the in vivo data. However,
KupVer cells showed the strongest expression among all
other stained cells (Fig. 8a–c).
Change in gene expression of MCRs in -MSH 
and THIQ-treated primary cultured rat KupVer cells 
and hepatocytes
We investigated the gene expression of MCRs at the
mRNA level in cultured KupVer cells and hepatocytes at
diVerent time points (2, 4 and 6 h) after treatment with
-MSH (MCRs agonist) and THIQ (speciWc MC4R agonist)
and compared them to non-treated controls for each time
point. An early and strong change in the gene expression of
MC4R (3.9 § 0.3-fold at 2 h) was observed after treatment
of KupVer cells with THIQ. Similar Wndings were also
observed in MC4R gene expression after treatment with
-MSH (MCRs agonist); however, the THIQ eVect was
faster and stronger. Moreover, stimulation with THIQ also
upregulated the gene expression of MC2R; this eVect was
stronger than that observed after treatment with -MSH.
Treatment of KupVer cells with -MSH upregulated gene
expression of MC3R followed by MC5R and MCR1,
whereas in comparison to non-treated controls, a mild
change was also detected in MC5R followed by MC3R and
MC1R at the mRNA level after treatment with THIQ
(Fig. 9).
Fig. 2 ImmunoXuorescence staining of liver sections with polyclonal
antibody directed against MC4R (red), followed by Xuorescent immu-
nodetection in rat liver sections during acute-phase response after TO
treatment.  Left control liver, right 6 h after TO treatment. Upper
MC4R and DAPI staining; middle MC4R staining; lower DAPI stain-
ing. Inset shows higher magniWcation. Results show the representative
picture of three animals and six slides per time point (original magni-
Wcation, £200, scale bar 20 m)Histochem Cell Biol (2012) 137:279–291 285
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By means of RT-PCR analysis, the presence of all
MCRs was also detected at the mRNA level in the isolated
cultured rat hepatocytes. Though lower in magnitude than
in the KupVer cells, a similar pattern of increase was
observed in the rat hepatocytes after -MSH and THIQ
treatment (data not shown).
Change in gene expression of acute-phase cytokines 
and chemokines in -MSH and THIQ-treated primary 
cultured KupVer cells and hepatocytes
In isolated KupVer cells, mRNA of pro-inXammatory cyto-
kines was signiWcantly increased compared to untreated
Fig. 3 ImmunoXuorescence staining in rat liver sections with mono-
clonal antibody against ED1 (upper left, green), polyclonal antibody
directed against MC4R (upper middle,  red) and merged ED1 and
MC4R (upper right);  middle staining with monoclonal antibody
against CK-19 (middle left,  green), polyclonal antibody directed
against MC4R (middle, red) and merged CK-19 and MC4R (middle
right); lower staining with monoclonal antibody against SMA (lower
left, green), polyclonal antibody directed against MC4R (middle, red)
and merged SMA and MC4R (lower right) followed by Xuorescent
immunodetection. Inset shows higher magniWcation. Results show the
representative picture of three animals and six slides per time point
(original magniWcation, £100, scale bar 20 m)
Fig. 4 ImmunoXuorescence staining of brain sections with polyclonal
antibody directed against MC4R (green) followed by Xuorescent
immunodetection in sections of rat brain during APR. a Control brain
section and b 6 h after TO treatment. Results show the representative
picture of three animals and six slides (original magniWcation, £100,
scale bar 10 m)286 Histochem Cell Biol (2012) 137:279–291
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controls upon exposure to LPS. The early (2 h) increase in
the cytokine group was observed with a maximum in gene
expression of TNF- at 4 h (182 § 15-fold), followed by
IL-6 (123 § 4-fold) and IL-1 (52 § 2-fold) at 6 h after
LPS treatment. The upregulating eVect of LPS on TNF-,
IL-6 and IL-1 was signiWcantly reduced by 40, 70 and
46%, respectively, by adding -MSH together with LPS in
culture medium. Gene expression of cytokines was also sig-
niWcantly reduced by the addition of THIQ together with
LPS; however, the reducing eVect of -MSH was higher on
IL-6 and IL1 than on THIQ. The reduction in gene expres-
sion of TNF- was similar with treatment of both molecules
in the presence of LPS (Fig. 10a).
In isolated cultured hepatocytes, gene expression of
CCL2 and CXCL10 was signiWcantly downregulated (up to
60%) after 4–6 h of exposure to -MSH or THIQ, respec-
tively (Fig. 10b).
Discussion
In this study, to the best of our knowledge, we demonstrate
for the Wrst time the presence of melanocortin receptors
(MCRs) in rat and mouse liver cells. An upregulation in
gene expression of MCRs in the liver and brain tissue was
detected in an acute-phase model induced by TO damage to
skeletal muscle. In parallel, an increase in -MSH level and
a signiWcant increase in leptin rat serum level were found.
After intramuscular TO injection, a “migration” of MC4R
protein from cytoplasm to the nucleus could be detected by
immunohistochemistry and Western blot analysis of the
cell fractions.
A similar pattern of increase in MC4R level was also
observed in the liver of two mice models of acute-phase
reaction, although the order of magnitude of the changes
observed in the liver of IL-6ko mice was much lower than
that observed in the wild-type animals.
To demonstrate the distribution and change of MC4R
gene expression in the liver taking place under the experi-
mental conditions used, we showed a change of MC4R
gene expression in rat brain tissue similar to that observed
in liver tissue. In fact, MC4R gene expression signiWcantly
increased during the time after tissue damage was induced
in the muscle. Both immunoprecipitation and Western blot
analysis showed a probable non-glycosylated (37 kDa) and
glycosylated (55 kDa) band of MC4R in liver tissue lysate.
In previous studies, in addition to a 55-kDa band, dimeriza-
tion of MC4R has also been reported (Biebermann et al.
2003; Elsner et al. 2006).
In contrast to treatments inducing an acute systemic
response and also liver damage, such as administering bac-
terial endotoxin LPS (Caruso et al. 2007), TO is known to
induce aseptic local abscesses without detectable injury to
other tissues (Malik et al. 2010a; Sheikh et al. 2006).
Therefore, the TO-induced APR model allows us to study
the eVect of cytokines produced at distant sites in the liver.
It reproduces the changes observed in human disease states
due to localized tissue injury (Malik et al. 2010a; Ramadori
and Christ 1999; Sheikh et al. 2006), making it an ideal
model for studying the metabolic consequences of human
APR.
The melanocortin system consists of several agonists,
apart from -MSH (native speciWc agonist of MCRs); the
discovery of an orally active non-peptide MC4R mimetic,
called THIQ (selective agonist of MC4R), has also been
reported (Sebhat et al. 2002). THIQ-stimulated 3,5-cyclic
monophosphate (cAMP) generation is reported to act simi-
larly to that induced by -MSH in human as well as in rat
MC4R assays (Sebhat et al. 2002). -MSH exerts its eVect
by melanocortin receptors (MCRs) and is known to be pro-
duced in the pituitary gland, brain and several peripheral
tissues, including immune cells, by posttranslational pro-
cessing of the pro-opiomelanocortin precursor protein
(Gantz and Fong 2003; Mountjoy et al. 1992; Tao 2010).
Fig. 5 ImmunoXuorescence staining of liver and brain sections during
APR. ImmunoXuorescence staining with polyclonal antibody directed
against MC3R a in liver sections (green) and b brain section (red) fol-
lowed by Xuorescent immunodetection during APR. Inset shows high-
er magniWcation. Results show the representative picture of three
animals and six slides (original magniWcation, £100, scale bar 10 m)Histochem Cell Biol (2012) 137:279–291 287
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We showed that MCRs were not only expressed in the
rat liver cells, but also that their gene expression was upreg-
ulated at the mRNA and protein level during acute-phase
response. An upregulation in MCRs gene expression is
known to be due to an increased concentration of their
agonist(s) (Gantz and Fong 2003). The binding of the ago-
nist to the receptor in the cytoplasm and its migration to the
nucleus could explain the increase of the MC4R protein in
the nuclear fraction during APR. In fact, this observed
migration of MC4R could be due to its binding not only to
-MSH, but also to leptin, as leptin is also able to directly
interact with the melanocortin system in mouse brain
(Vrang et al. 2002), and inhibition of MC4R attenuates the
leptin signaling in rat brain (Seeley et al. 1997). This could
be true for liver as well, because an increased serum level
of leptin was also detected in our studied model. Moreover,
Fig. 6 Detection of MC4R and MC3R by Western blot analysis of rat
liver and brain. a Western blot analysis revealed two immunoreactive
bands: one at 37 kDa and a second at 55 kDa. Lane (L)1 contains rat
liver total lysate, L2 liver cytosolic extraction, L3 liver nuclear extracts
and L4 total protein of cultured rat hepatocytes. b Top rat liver total
lysates with immunoreactive bands at 37 and 55 kDa, middle after neu-
tralizing the anti-MC4R antibody with a speciWc immunizing peptide.
Bottom reprobing of the same membrane with the antibody against
MC4R without immunizing peptide. c Changes in MC4R protein level
during APR. Top contains rat liver total lysate, middle liver cytosolic
extraction, bottom liver nuclear extracts. d IdentiWcation and changes
in MC4R level in rat brain total lysate during APR, e detection and
changes of MC3R level in rat liver total lysate. f Changes in serum
concentration of -MSH and leptin during APR. -MSH (top) and lep-
tin (bottom) levels were measured with enzyme-linked immunosorbent
assay (ELISA). Results represent mean value § SEM (*P < 0.05 ana-
lyzed by one-way ANOVA; n =3 ) .   g Detection of MC4R in the liver
of wild-type and IL-6-ko mice during APR. Total protein lysate of
mouse liver after TO administration; h total protein lysate of mice liver
after LPS treatment. -actin (43 kDa) was used as equal loading con-
trol in Western blot analysis. Results show the representative picture of
three animals288 Histochem Cell Biol (2012) 137:279–291
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leptin receptors are known to be expressed in hepatocytes
(Cohen et al. 2007). A similar mechanism of cytoplasm to
nuclear movement has already been reported in glucocorti-
coid receptors (Picard and Yamamoto 1987) and insulin
receptors (Fehlmann et al. 1982) after binding to their
ligand. A link between and leptin and the melanocortin sys-
tem has already been established. A previous study on rats
showed that leptin regulates the glucose Xuxes of hepatic
and peripheral tissues through a melanocortin-dependent
pathway (Shimizu et al. 2007; Toda et al. 2009). Another
study stated that mice lacking OB-Rb (leptin receptor) in
POMC neurons show hyperinsulinemia (van de Wall et al.
2008). Likewise, glucose uptake by the eVect of intra-ven-
tromedial nucleus of the hypothalamus (VMH) leptin also
depends on MC4R (Toda et al. 2009). Together, these stud-
ies clearly support a relationship between leptin and the
melanocortin system of the brain.
As we previously showed, the serum level of IL-6 is dra-
matically elevated in the rat model of TO-induced APR
(Sheikh et al. 2006). In this study, we analyze MC4R gene
expression in IL-6ko mice using the same APR model.
Strikingly, in the absence of IL-6, the increase of MC4R
hepatic gene expression after TO injection was much lower
than that observed in wild-type animals, indicating a direct,
regulative function of this important acute-phase cytokine.
A contribution of cytokines (IL-6 and TNF-) to the
manifestation of whole-body insulin resistance and to the
direct regulation of glucose metabolism has already been
described (Lazar 2005; Wallenius et al. 2002). Further-
more, IL-6 given peripherally at high doses can cause
increased levels of blood lipids and blood glucose
(Nonogaki et al. 1995). Administration of IL-6 could stimu-
late the mobilization and utilization of fatty acids and could
also increase lipid metabolism (Glund and Krook 2008).
Moreover, it can also acutely enhance circulating levels of
triglycerides in rats (Nonogaki et al. 1995), suggesting the
importance of this cytokine in APR-induced metabolic dis-
order.
The relation between leptin and melanocortin or leptin
and cytokines has been studied partially (Shimizu et al.
2007; Vrang et al. 2002; Wallenius et al. 2002); however,
Fig. 8 ImmunoXuorescence detection of MC4R in isolated rat a KupVer cells, b hepatocytes and c human hepatoma cell line (HepG2). Results
are representative of three experiments for each cell type (original magniWcation £400, scale bar 40 m)
Fig. 7 Double immunoXuorescence staining with polyclonal antibody
directed against MC4R (red) and F4/80 (green) followed by Xuores-
cent immunodetection in sections of mouse liver during APR. Upper
control liver, lower 6 h after TO treatment. Inset shows higher magni-
Wcation. White arrow indicates the hepatocytes positive for MC4R and
white arrowhead indicates the KupVer cells positive for MC4R and F4/
80. Results show the representative picture of three animals and six
slides (original magniWcation, £200, scale bar 20 m)Histochem Cell Biol (2012) 137:279–291 289
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interaction among leptin, the melanocortin system and
cytokines together has not been investigated so far. A pre-
vious report stated that despite the absence of IL-6, the
serum leptin level was increased in IL-6ko mice during
APR (Faggioni et al. 1998; Wallenius et al. 2002). This
could suggest that although MC4R gene expression is not
upregulated in the absence of IL-6, a strong metabolic eVect
could be achieved by the interaction between leptin and
MC4R.
Consideration of our data further implies that the mela-
nocortin system could have a dual role: on one hand,
MC4R is not only the target of acute-phase cytokines, but
may control their production as well.
In this study, we show that the melanocortin system
inXuences energy metabolism at diVerent levels during
APR. In fact, it not only mediates the eVect of acute-phase
cytokines, but may also participate in controlling the syn-
thesis of APR cytokines and chemokines in liver macro-
phages (KupVer cells) and hepatocytes respectively. The
latter have also been shown to have metabolic eVects
(Sartipy and LoskutoV 2003; Sell and Eckel 2009).
Indeed, in our current study, treatment of KupVer cells
with endotoxin lipopolysaccharide (LPS) increased gene
expression of acute-phase mediators; this increase was sig-
niWcantly inhibited by -MSH and THIQ, respectively.
Moreover, both agonists were able to downregulate the
gene expression of potential chemokines in cultured rat
hepatocytes.
In an additional experiment, IL-6 treatment of hepatocytes
increased the gene expression of two major acute-phase
proteins: 2-macroglobulin (2M) and heme oxygenase-1
(HO-1); however, this upregulation of 2M was transiently
reduced in hepatocytes when -MSH was also added in the
culture medium. In contrast, the eVect of IL-6 on expres-
sion of HO-1 was not reduced by -MSH (manuscript in
preparation). It may suggest that the main role of MC4R is
Fig. 9 RT-PCR analysis of total RNA from rat isolated KupVer cells
treated with -MSH and THIQ. Data shown as fold changes in mRNA
expression of MC1R, MC2R, MC3R, MC4R and MC5R at diVerent
time points related to untreated controls for each time point. qRT-PCR
was normalized by using two housekeeping genes: -actin and ubiqui-
tin C. Results represent mean value § SEM of three experiments,
*p <0 . 0 5290 Histochem Cell Biol (2012) 137:279–291
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to reduce possible pro-inXammatory consequences of
acute-phase cytokines, such as production of chemokines
and not the production of anti-inXammatory proteins (e.g.,
antiprotease).
Recently, a study on mice reported a protective eVect of
-MSH against experimental multiple organs (including
liver) dysfunction syndrome (MODS) by counteracting the
systemic inXammatory response. The protective eVect is
suggested through brain MC4R-triggered activation of the
cholinergic anti-inXammatory pathway, which is counter-
acted and inhibited by the administration of the MC4R
antagonist (HS024) (Bitto et al. 2011). However, our data
oVer a possible alternative or additional explanation by indi-
cating that MC4R plays a more direct role within liver cells.
In conclusion, the presence of MCRs in liver cells
strongly suggests their role in liver energy metabolism.
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